Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for TBPH

Stock NameTheravance Biopharma Inc
TickerTBPH(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINKYG8807B1068
LEI5493007VTSXP4Z6MIW52

Show aggregate TBPH holdings

News associated with TBPH

Theravance Biopharma, Inc. (NASDAQ:TBPH) Short Interest Up 25.3% in August
Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) was the target of a significant increase in short interest in August. As of August 31st, there was short interest totaling 4,460,000 shares, an increase of 25.3% from the August 15th total of 3,560,000 shares. Based on an average trading volume of 333,700 shares, the short-interest ratio […] - 2025-09-19 04:28:56
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Average Recommendation of “Strong Buy” by Analysts
Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) has been given an average recommendation of “Strong Buy” by the five brokerages that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a buy rating and three have given a strong buy rating to the company. The average 12-month target price […] - 2025-09-17 02:58:46
Theravance Biopharma (NASDAQ:TBPH) Hits New 1-Year High Following Strong Earnings
Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday following a stronger than expected earnings report. The stock traded as high as $11.88 and last traded at $11.89, with a volume of 195285 shares. The stock had previously closed at $11.40. The biopharmaceutical company […] - 2025-08-13 02:58:43
Bank of New York Mellon Corp Raises Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH)
Bank of New York Mellon Corp grew its stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 1.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 117,499 shares of the biopharmaceutical company’s stock after buying an additional 1,720 shares during the […] - 2025-08-01 04:26:59
Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Bought by GSA Capital Partners LLP
GSA Capital Partners LLP raised its position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 11.9% during the 1st quarter, HoldingsChannel.com reports. The firm owned 182,350 shares of the biopharmaceutical company’s stock after acquiring an additional 19,363 shares during the period. GSA Capital Partners LLP’s holdings in Theravance Biopharma were worth $1,628,000 at the […] - 2025-07-30 04:44:43
Alps Advisors Inc. Sells 3,680 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH)
Alps Advisors Inc. decreased its position in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 9.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 36,079 shares of the biopharmaceutical company’s stock after selling 3,680 shares during the period. […] - 2025-07-18 04:49:01
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Recommendation of “Moderate Buy” by Analysts
Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and one has given a strong buy recommendation […] - 2025-07-17 04:40:54
Jones Trading Initiates Coverage on Theravance Biopharma (NASDAQ:TBPH)
Jones Trading initiated coverage on shares of Theravance Biopharma (NASDAQ:TBPH – Get Free Report) in a note issued to investors on Tuesday,Benzinga reports. The firm set a “buy” rating and a $24.00 price target on the biopharmaceutical company’s stock. Jones Trading’s target price suggests a potential upside of 125.99% from the stock’s current price. TBPH […] - 2025-06-19 02:18:55
Wellington Management Group LLP Acquires 7,162 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH)
Wellington Management Group LLP raised its stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 3.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 198,491 shares of the biopharmaceutical company’s stock after buying an additional 7,162 shares during […] - 2025-06-06 06:12:49
Public Employees Retirement System of Ohio Buys New Position in Theravance Biopharma, Inc. (NASDAQ:TBPH)
Public Employees Retirement System of Ohio bought a new stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 37,461 shares of the biopharmaceutical company’s stock, valued at approximately $353,000. Other hedge funds […] - 2025-06-05 06:14:52
Squarepoint Ops LLC Has $444,000 Position in Theravance Biopharma, Inc. (NASDAQ:TBPH)
Squarepoint Ops LLC cut its position in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 52.3% in the fourth quarter, Holdings Channel reports. The institutional investor owned 47,168 shares of the biopharmaceutical company’s stock after selling 51,783 shares during the period. Squarepoint Ops LLC’s holdings in Theravance Biopharma were worth $444,000 as of […] - 2025-06-05 05:16:56
ProShare Advisors LLC Acquires New Position in Theravance Biopharma, Inc. (NASDAQ:TBPH)
ProShare Advisors LLC acquired a new stake in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 12,672 shares of the biopharmaceutical company’s stock, valued at approximately $119,000. A number of other hedge funds have also added to or reduced their stakes in TBPH. Newtyn Management LLC […] - 2025-06-03 05:26:49
Ameriprise Financial Inc. Lowers Stock Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH)
Ameriprise Financial Inc. reduced its stake in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 9.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 100,807 shares of the biopharmaceutical company’s stock after selling 10,825 shares during the period. Ameriprise Financial Inc.’s holdings in […] - 2025-06-02 04:19:00
Man Group plc Sells 14,851 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH)
Man Group plc reduced its stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 59.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,328 shares of the biopharmaceutical company’s stock after selling 14,851 shares during the quarter. Man […] - 2025-05-29 05:36:58
Dimensional Fund Advisors LP Has $5.21 Million Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH)
Dimensional Fund Advisors LP raised its position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 20.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 553,713 shares of the biopharmaceutical company’s stock after buying an additional 95,304 shares during the […] - 2025-05-13 06:14:52
Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Bought by Tower Research Capital LLC TRC
Tower Research Capital LLC TRC grew its position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 142.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 12,670 shares of the biopharmaceutical company’s stock after purchasing an additional 7,452 shares during the period. Tower Research Capital […] - 2025-05-09 05:22:54
Barclays PLC Raises Position in Theravance Biopharma, Inc. (NASDAQ:TBPH)
Barclays PLC increased its position in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 14.0% in the 4th quarter, HoldingsChannel reports. The firm owned 74,790 shares of the biopharmaceutical company’s stock after purchasing an additional 9,210 shares during the period. Barclays PLC’s holdings in Theravance Biopharma were worth $704,000 as of its most […] - 2025-05-08 04:36:46
XTX Topco Ltd Reduces Stock Position in Theravance Biopharma, Inc. (NASDAQ:TBPH)
XTX Topco Ltd lessened its holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 20.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 16,356 shares of the biopharmaceutical company’s stock after selling 4,083 shares during the period. XTX Topco Ltd’s holdings in Theravance […] - 2025-04-29 05:24:51
10,937 Shares in Theravance Biopharma, Inc. (NASDAQ:TBPH) Bought by Teacher Retirement System of Texas
Teacher Retirement System of Texas acquired a new position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 10,937 shares of the biopharmaceutical company’s stock, valued at approximately $103,000. Other institutional investors have […] - 2025-04-03 04:16:48
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Rating of “Hold” by Analysts
Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) have been assigned a consensus rating of “Hold” from the five brokerages that are covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month price […] - 2025-03-27 04:55:16
Bank of New York Mellon Corp Sells 5,282 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH)
Bank of New York Mellon Corp trimmed its stake in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 4.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 115,779 shares of the biopharmaceutical company’s stock after selling 5,282 shares during the quarter. Bank of New York Mellon Corp’s holdings in Theravance Biopharma were worth $1,089,000 […] - 2025-03-25 05:14:50
Theravance Biopharma (NASDAQ:TBPH) Receives Buy Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Theravance Biopharma (NASDAQ:TBPH – Free Report) in a research report report published on Tuesday,Benzinga reports. They currently have a $15.00 price objective on the biopharmaceutical company’s stock. Theravance Biopharma Trading Up 1.2 % TBPH opened at $8.97 on Tuesday. Theravance Biopharma has a 12-month low of […] - 2025-02-26 06:49:00

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) TBPH holdings

DateNumber of TBPH Shares HeldBase Market Value of TBPH SharesLocal Market Value of TBPH SharesChange in TBPH Shares HeldChange in TBPH Base ValueCurrent Price per TBPH Share HeldPrevious Price per TBPH Share Held
2025-11-11 (Tuesday)32,359USD 598,642TBPH holding increased by 110668USD 598,6420USD 110,668 USD 18.5 USD 15.08
2025-11-10 (Monday)32,359TBPH holding increased by 83USD 487,974TBPH holding increased by 11903USD 487,97483USD 11,903 USD 15.08 USD 14.75
2025-11-07 (Friday)32,276USD 476,071TBPH holding decreased by -3873USD 476,0710USD -3,873 USD 14.75 USD 14.87
2025-11-06 (Thursday)32,276TBPH holding increased by 83USD 479,944TBPH holding decreased by -1341USD 479,94483USD -1,341 USD 14.87 USD 14.95
2025-11-05 (Wednesday)32,193USD 481,285TBPH holding increased by 6438USD 481,2850USD 6,438 USD 14.95 USD 14.75
2025-11-04 (Tuesday)32,193TBPH holding increased by 84USD 474,847TBPH holding decreased by -13852USD 474,84784USD -13,852 USD 14.75 USD 15.22
2025-11-03 (Monday)32,109USD 488,699TBPH holding increased by 17981USD 488,6990USD 17,981 USD 15.22 USD 14.66
2025-10-31 (Friday)32,109USD 470,718TBPH holding increased by 11559USD 470,7180USD 11,559 USD 14.66 USD 14.3
2025-10-30 (Thursday)32,109TBPH holding increased by 420USD 459,159TBPH holding increased by 10126USD 459,159420USD 10,126 USD 14.3 USD 14.17
2025-10-29 (Wednesday)31,689TBPH holding increased by 168USD 449,033TBPH holding increased by 4587USD 449,033168USD 4,587 USD 14.17 USD 14.1
2025-10-28 (Tuesday)31,521USD 444,446TBPH holding decreased by -6304USD 444,4460USD -6,304 USD 14.1 USD 14.3
2025-10-27 (Monday)31,521USD 450,750TBPH holding increased by 630USD 450,7500USD 630 USD 14.3 USD 14.28
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TBPH by Blackrock for IE00BYXG2H39

Show aggregate share trades of TBPH

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY83 15.080* 10.47
2025-11-06BUY83 14.870* 10.43
2025-11-04BUY84 14.750* 10.38
2025-10-30BUY42014.35014.150 14.170USD 5,951 10.31
2025-10-29BUY16814.17014.420 14.395USD 2,418 10.29
2025-10-22SELL-33214.00014.043 14.039USD -4,661 10.19 Loss of -1,278 on sale
2025-10-20BUY16614.31014.410 14.400USD 2,390 10.15
2025-10-17BUY41514.26014.335 14.328USD 5,946 10.12
2025-10-15BUY66413.90014.590 14.521USD 9,642 10.10
2025-10-03BUY58814.41014.435 14.433USD 8,486 10.06
2025-10-02BUY8414.07014.520 14.475USD 1,216 10.03
2025-09-30BUY16814.60014.870 14.843USD 2,494 9.98
2025-09-26BUY16814.07014.140 14.133USD 2,374 9.93
2025-09-25BUY16813.79014.040 14.015USD 2,355 9.91
2025-09-24SELL-2,28014.05014.390 14.356USD -32,732 9.89 Loss of -10,187 on sale
2025-09-18BUY9114.47014.500 14.497USD 1,319 9.86
2025-09-17BUY27614.05014.150 14.140USD 3,903 9.84
2025-08-20SELL-36013.39013.515 13.503USD -4,861 9.74 Loss of -1,353 on sale
2025-07-30BUY36011.07011.260 11.241USD 4,047 9.65
2025-07-17SELL-18011.62011.880 11.854USD -2,134 9.56 Loss of -413 on sale
2025-07-11SELL-72811.30011.410 11.399USD -8,298 9.51 Loss of -1,377 on sale
2025-07-07BUY27311.31011.320 11.319USD 3,090 9.45
2025-07-02BUY5,00511.05011.170 11.158USD 55,846 9.43
2025-06-20BUY2,49710.63010.690 10.684USD 26,678 9.42
2025-06-11BUY16610.61010.780 10.763USD 1,787 9.36
2025-06-10BUY16610.73011.040 11.009USD 1,827 9.35
2025-06-04SELL-8311.01011.169 11.153USD -926 9.30 Loss of -154 on sale
2025-04-23BUY839.4509.510 9.504USD 789 9.21
2025-04-10SELL-6648.3908.430 8.426USD -5,595 9.26 Profit of 551 on sale
2025-04-08SELL-838.3209.160 9.076USD -753 9.27 Profit of 16 on sale
2025-04-07SELL-838.4108.660 8.635USD -717 9.28 Profit of 54 on sale
2025-04-04SELL-4158.4408.640 8.620USD -3,577 9.29 Profit of 280 on sale
2025-04-01BUY3409.0209.090 9.083USD 3,088 9.30
2025-03-31SELL-2528.9309.150 9.128USD -2,300 9.31 Profit of 45 on sale
2025-03-14SELL-1,3609.2309.400 9.383USD -12,761 9.30 Loss of -109 on sale
2025-03-07SELL-1709.5309.910 9.872USD -1,678 9.30 Loss of -98 on sale
2025-03-04SELL-859.1009.220 9.208USD -783 9.29 Profit of 7 on sale
2025-02-25BUY1708.9709.140 9.123USD 1,551 9.30
2025-02-19SELL-849.7509.760 9.759USD -820 9.29 Loss of -40 on sale
2025-02-13BUY2529.4809.595 9.584USD 2,415 9.27
2025-02-12BUY849.3609.400 9.396USD 789 9.27
2025-02-11BUY3369.0409.485 9.440USD 3,172 9.27
2024-12-30SELL-4259.4709.720 9.695USD -4,120 9.13 Loss of -239 on sale
2024-11-18SELL-1,2459.4909.675 9.657USD -12,022 8.59 Loss of -1,325 on sale
2024-11-08SELL-838.9408.950 8.949USD -743 8.55 Loss of -34 on sale
2024-10-21SELL-858.6608.780 8.768USD -745 0.00 Loss of -745 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TBPH

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1946,143069,38466.5%
2025-09-1880,190117112,01271.6%
2025-09-1775,5940114,22166.2%
2025-09-1670,7650139,69050.7%
2025-09-15105,409400172,83961.0%
2025-09-12136,735151333,53041.0%
2025-09-1174,0190120,26961.5%
2025-09-1073,4840124,15159.2%
2025-09-0969,711097,56971.4%
2025-09-0871,9360104,44268.9%
2025-09-05144,1790270,63553.3%
2025-09-04113,312100178,97763.3%
2025-09-03147,2450195,02375.5%
2025-09-02210,6440362,99158.0%
2025-08-29143,618600181,27579.2%
2025-08-2891,8510163,38356.2%
2025-08-2738,465086,67344.4%
2025-08-2655,7550101,81254.8%
2025-08-25176,328101,189252,59469.8%
2025-08-22126,2660309,77340.8%
2025-08-21108,9940183,42759.4%
2025-08-2064,55616,67288,17873.2%
2025-08-1962,998230140,05445.0%
2025-08-18128,4990383,24433.5%
2025-08-1575,5620251,50130.0%
2025-08-14108,2130315,70934.3%
2025-08-13102,3020184,57555.4%
2025-08-1275,6780174,75943.3%
2025-08-1140,324088,88645.4%
2025-08-0837,6510439,9058.6%
2025-08-0716,105037,94642.4%
2025-08-0628,678042,92366.8%
2025-08-0538,161059,31964.3%
2025-08-0435,7174461,07458.5%
2025-08-0130,9431,10042,16073.4%
2025-07-3131,614042,70474.0%
2025-07-3033,096053,70461.6%
2025-07-2917,238034,55549.9%
2025-07-2815,392034,14945.1%
2025-07-2531,283043,72071.6%
2025-07-2410,550026,05840.5%
2025-07-2322,148031,10071.2%
2025-07-2220,402031,93663.9%
2025-07-2118,084037,42748.3%
2025-07-1821,942934,99262.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.